A newly developed targeted radiopharmaceutical treatment can effectively slow tumor growth in pancreatic ductal ...
Virginia Cancer Specialists announced today its participation as a leading clinical trial site in a landmark study evaluating daraxonrasib, a first‑in‑class targeted oral therapy for patients with ...
A newly developed therapy inspired by bacteria residing within tumors offers a different way to combat cancer by targeting ...
Treating breast cancer that has begun to spread around the body with targeted radiotherapy could help patients to live longer ...
Targeted therapies are cancer medications that work more selectively than standard chemotherapy medications. They do this by targeting specific molecules or genetic changes in cancer cells in order to ...
A targeted drug-delivery system called TAMP aims to send chemotherapy near pancreatic tumors instead of through the entire ...
Folate receptor alpha (FRα) is a promising target for therapies against certain cancers, especially ovarian cancer and lung adenocarcinoma. Market opportunities are driven by innovative ADCs, small ...
Enzalutamide Plus Leuprolide Extends Treatment Suspension in Biochemically Recurrent Prostate Cancer
An ITT reanalysis assigning 0-month suspension to non-suspenders addressed imbalance in suspension rates (90% combination, 86 ...
Targeted therapies are medicines to treat cancer. They work differently than standard chemotherapy. Instead of killing all fast-growing cells or keeping them from dividing, targeted therapies work ...
A potential breakthrough in the fight against glioblastoma, the deadliest form of brain cancer, is emerging from UVA Cancer Center. University of Virginia scientists, with support from the National ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results